Does the media prefer CCAP or MFIC?

In the previous week, Crescent Capital BDC and Crescent Capital BDC both had 1 articles in the media. MidCap Financial Investment's average media sentiment score of 0.00 beat Crescent Capital BDC's score of -0.20 indicating that MidCap Financial Investment is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Crescent Capital BDC 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral MidCap Financial Investment 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to CCAP or SLRC?

In the previous week, Crescent Capital BDC and Crescent Capital BDC both had 1 articles in the media. SLR Investment's average media sentiment score of 1.36 beat Crescent Capital BDC's score of -0.20 indicating that SLR Investment is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Crescent Capital BDC 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SLR Investment 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to CCAP or GSBD?

In the previous week, Crescent Capital BDC and Crescent Capital BDC both had 1 articles in the media. Goldman Sachs BDC's average media sentiment score of 0.00 beat Crescent Capital BDC's score of -0.20 indicating that Goldman Sachs BDC is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Crescent Capital BDC 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Goldman Sachs BDC 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Crescent Capital BDC (CCAP) Competitors

$11.27 +0.08 (+0.71%)

Closing price 04:00 PM Eastern

Extended Trading

$11.48 +0.22 (+1.91%)

As of 06:23 PM Eastern

Compare

CCAP vs. CGBD, MFIC, SLRC, BCSF, and GSBD

Should you buy Crescent Capital BDC stock or one of its competitors? MarketBeat compares Crescent Capital BDC with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Crescent Capital BDC include Carlyle Secured Lending (CGBD), MidCap Financial Investment (MFIC), SLR Investment (SLRC), Bain Capital Specialty Finance (BCSF), and Goldman Sachs BDC (GSBD). These companies are all part of the "finance" sector.

How does Crescent Capital BDC compare to Carlyle Secured Lending?

Carlyle Secured Lending (NASDAQ:CGBD) and Crescent Capital BDC (NASDAQ:CCAP) are both small-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings and analyst recommendations.

Carlyle Secured Lending has higher earnings, but lower revenue than Crescent Capital BDC. Carlyle Secured Lending is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carlyle Secured Lending	$63.06M	11.81	$69.97M	$0.71	15.10
Crescent Capital BDC	$167.29M	2.48	$34.51M	$0.41	27.49

In the previous week, Crescent Capital BDC had 1 more articles in the media than Carlyle Secured Lending. MarketBeat recorded 1 mentions for Crescent Capital BDC and 0 mentions for Carlyle Secured Lending. Carlyle Secured Lending's average media sentiment score of 0.00 beat Crescent Capital BDC's score of -0.20 indicating that Carlyle Secured Lending is being referred to more favorably in the media.

Company	Overall Sentiment
Carlyle Secured Lending	Neutral
Crescent Capital BDC	Neutral

Carlyle Secured Lending presently has a consensus price target of $12.50, suggesting a potential upside of 16.60%. Crescent Capital BDC has a consensus price target of $13.90, suggesting a potential upside of 23.34%. Given Crescent Capital BDC's higher probable upside, analysts plainly believe Crescent Capital BDC is more favorable than Carlyle Secured Lending.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carlyle Secured Lending	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43
Crescent Capital BDC	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

Carlyle Secured Lending has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market.

Carlyle Secured Lending has a net margin of 19.52% compared to Crescent Capital BDC's net margin of 9.26%. Crescent Capital BDC's return on equity of 9.34% beat Carlyle Secured Lending's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Carlyle Secured Lending	19.52%	8.99%	4.01%
Crescent Capital BDC	9.26%	9.34%	4.04%

24.5% of Carlyle Secured Lending shares are owned by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are owned by institutional investors. 0.4% of Carlyle Secured Lending shares are owned by insiders. Comparatively, 1.2% of Crescent Capital BDC shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Carlyle Secured Lending pays an annual dividend of $1.40 per share and has a dividend yield of 13.1%. Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 14.9%. Carlyle Secured Lending pays out 197.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out 409.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has raised its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Crescent Capital BDC beats Carlyle Secured Lending on 10 of the 19 factors compared between the two stocks.

How does Crescent Capital BDC compare to MidCap Financial Investment?

Crescent Capital BDC (NASDAQ:CCAP) and MidCap Financial Investment (NASDAQ:MFIC) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

Crescent Capital BDC currently has a consensus price target of $13.90, suggesting a potential upside of 23.34%. MidCap Financial Investment has a consensus price target of $11.54, suggesting a potential upside of 16.76%. Given Crescent Capital BDC's higher probable upside, analysts plainly believe Crescent Capital BDC is more favorable than MidCap Financial Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Crescent Capital BDC	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
MidCap Financial Investment	0 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.22

In the previous week, Crescent Capital BDC and Crescent Capital BDC both had 1 articles in the media. MidCap Financial Investment's average media sentiment score of 0.00 beat Crescent Capital BDC's score of -0.20 indicating that MidCap Financial Investment is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Crescent Capital BDC	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
MidCap Financial Investment	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Crescent Capital BDC has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market. Comparatively, MidCap Financial Investment has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market.

MidCap Financial Investment has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than MidCap Financial Investment, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crescent Capital BDC	$167.29M	2.48	$34.51M	$0.41	27.49
MidCap Financial Investment	$320.88M	2.54	$63.17M	$0.04	247.00

Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 14.9%. MidCap Financial Investment pays an annual dividend of $1.24 per share and has a dividend yield of 12.6%. Crescent Capital BDC pays out 409.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. MidCap Financial Investment pays out 3,100.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Crescent Capital BDC has a net margin of 9.26% compared to MidCap Financial Investment's net margin of 1.90%. MidCap Financial Investment's return on equity of 10.86% beat Crescent Capital BDC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Crescent Capital BDC	9.26%	9.34%	4.04%
MidCap Financial Investment	1.90%	10.86%	4.31%

49.5% of Crescent Capital BDC shares are owned by institutional investors. Comparatively, 28.5% of MidCap Financial Investment shares are owned by institutional investors. 1.2% of Crescent Capital BDC shares are owned by company insiders. Comparatively, 0.9% of MidCap Financial Investment shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

MidCap Financial Investment beats Crescent Capital BDC on 9 of the 17 factors compared between the two stocks.

How does Crescent Capital BDC compare to SLR Investment?

Crescent Capital BDC (NASDAQ:CCAP) and SLR Investment (NASDAQ:SLRC) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.

Crescent Capital BDC has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market. Comparatively, SLR Investment has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market.

Crescent Capital BDC currently has a consensus target price of $13.90, suggesting a potential upside of 23.34%. SLR Investment has a consensus target price of $14.40, suggesting a potential upside of 15.76%. Given Crescent Capital BDC's stronger consensus rating and higher possible upside, analysts clearly believe Crescent Capital BDC is more favorable than SLR Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Crescent Capital BDC	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
SLR Investment	3 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.86

SLR Investment has a net margin of 41.81% compared to Crescent Capital BDC's net margin of 9.26%. Crescent Capital BDC's return on equity of 9.34% beat SLR Investment's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Crescent Capital BDC	9.26%	9.34%	4.04%
SLR Investment	41.81%	8.33%	3.25%

SLR Investment has higher revenue and earnings than Crescent Capital BDC. SLR Investment is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crescent Capital BDC	$167.29M	2.48	$34.51M	$0.41	27.49
SLR Investment	$218.54M	3.11	$92.54M	$1.64	7.59

Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 14.9%. SLR Investment pays an annual dividend of $1.24 per share and has a dividend yield of 10.0%. Crescent Capital BDC pays out 409.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. SLR Investment pays out 75.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Crescent Capital BDC and Crescent Capital BDC both had 1 articles in the media. SLR Investment's average media sentiment score of 1.36 beat Crescent Capital BDC's score of -0.20 indicating that SLR Investment is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Crescent Capital BDC	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SLR Investment	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

49.5% of Crescent Capital BDC shares are held by institutional investors. Comparatively, 35.3% of SLR Investment shares are held by institutional investors. 1.2% of Crescent Capital BDC shares are held by company insiders. Comparatively, 8.8% of SLR Investment shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

SLR Investment beats Crescent Capital BDC on 9 of the 17 factors compared between the two stocks.

How does Crescent Capital BDC compare to Bain Capital Specialty Finance?

Crescent Capital BDC (NASDAQ:CCAP) and Bain Capital Specialty Finance (NYSE:BCSF) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation, institutional ownership and media sentiment.

Crescent Capital BDC has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market. Comparatively, Bain Capital Specialty Finance has a beta of 0.57, indicating that its stock price is 43% less volatile than the broader market.

In the previous week, Crescent Capital BDC had 1 more articles in the media than Bain Capital Specialty Finance. MarketBeat recorded 1 mentions for Crescent Capital BDC and 0 mentions for Bain Capital Specialty Finance. Bain Capital Specialty Finance's average media sentiment score of 0.00 beat Crescent Capital BDC's score of -0.20 indicating that Bain Capital Specialty Finance is being referred to more favorably in the news media.

Company	Overall Sentiment
Crescent Capital BDC	Neutral
Bain Capital Specialty Finance	Neutral

Crescent Capital BDC presently has a consensus price target of $13.90, indicating a potential upside of 23.34%. Bain Capital Specialty Finance has a consensus price target of $14.00, indicating a potential upside of 15.42%. Given Crescent Capital BDC's higher possible upside, analysts clearly believe Crescent Capital BDC is more favorable than Bain Capital Specialty Finance.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Crescent Capital BDC	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Bain Capital Specialty Finance	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

49.5% of Crescent Capital BDC shares are held by institutional investors. 1.2% of Crescent Capital BDC shares are held by company insiders. Comparatively, 0.6% of Bain Capital Specialty Finance shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 14.9%. Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 13.8%. Crescent Capital BDC pays out 409.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bain Capital Specialty Finance pays out 147.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has raised its dividend for 1 consecutive years and Bain Capital Specialty Finance has raised its dividend for 4 consecutive years.

Bain Capital Specialty Finance has a net margin of 27.00% compared to Crescent Capital BDC's net margin of 9.26%. Bain Capital Specialty Finance's return on equity of 10.44% beat Crescent Capital BDC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Crescent Capital BDC	9.26%	9.34%	4.04%
Bain Capital Specialty Finance	27.00%	10.44%	4.35%

Bain Capital Specialty Finance has lower revenue, but higher earnings than Crescent Capital BDC. Bain Capital Specialty Finance is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crescent Capital BDC	$167.29M	2.48	$34.51M	$0.41	27.49
Bain Capital Specialty Finance	$88.67M	8.87	$98.76M	$1.14	10.64

Summary

Bain Capital Specialty Finance beats Crescent Capital BDC on 11 of the 19 factors compared between the two stocks.

How does Crescent Capital BDC compare to Goldman Sachs BDC?

Crescent Capital BDC (NASDAQ:CCAP) and Goldman Sachs BDC (NYSE:GSBD) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation.

Crescent Capital BDC has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market. Comparatively, Goldman Sachs BDC has a beta of 0.58, indicating that its stock price is 42% less volatile than the broader market.

Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 14.9%. Goldman Sachs BDC pays an annual dividend of $1.28 per share and has a dividend yield of 13.5%. Crescent Capital BDC pays out 409.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Goldman Sachs BDC pays out 196.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

49.5% of Crescent Capital BDC shares are owned by institutional investors. Comparatively, 28.7% of Goldman Sachs BDC shares are owned by institutional investors. 1.2% of Crescent Capital BDC shares are owned by insiders. Comparatively, 0.1% of Goldman Sachs BDC shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Goldman Sachs BDC has a net margin of 21.32% compared to Crescent Capital BDC's net margin of 9.26%. Goldman Sachs BDC's return on equity of 10.94% beat Crescent Capital BDC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Crescent Capital BDC	9.26%	9.34%	4.04%
Goldman Sachs BDC	21.32%	10.94%	4.66%

Goldman Sachs BDC has higher revenue and earnings than Crescent Capital BDC. Goldman Sachs BDC is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crescent Capital BDC	$167.29M	2.48	$34.51M	$0.41	27.49
Goldman Sachs BDC	$365.57M	2.91	$119.27M	$0.65	14.54

Crescent Capital BDC currently has a consensus target price of $13.90, indicating a potential upside of 23.34%. Goldman Sachs BDC has a consensus target price of $9.17, indicating a potential downside of 3.00%. Given Crescent Capital BDC's stronger consensus rating and higher probable upside, analysts plainly believe Crescent Capital BDC is more favorable than Goldman Sachs BDC.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Crescent Capital BDC	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Goldman Sachs BDC	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

In the previous week, Crescent Capital BDC and Crescent Capital BDC both had 1 articles in the media. Goldman Sachs BDC's average media sentiment score of 0.00 beat Crescent Capital BDC's score of -0.20 indicating that Goldman Sachs BDC is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Crescent Capital BDC	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Goldman Sachs BDC	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Goldman Sachs BDC beats Crescent Capital BDC on 10 of the 18 factors compared between the two stocks.

Get Crescent Capital BDC News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CCAP vs. The Competition

Export

Metric	Crescent Capital BDC	FIN Industry	Finance Sector	NASDAQ Exchange
Market Cap	$415.30M	$1.26B	$13.96B	$12.11B
Dividend Yield	15.03%	13.38%	5.74%	5.81%
P/E Ratio	27.49	10.75	20.23	24.00
Price / Sales	2.48	17.88	139.81	102.74
Price / Cash	6.51	6.87	19.54	37.84
Price / Book	0.59	0.75	2.25	6.53
Net Income	$34.51M	$121.13M	$1.14B	$336.99M
7 Day Performance	-0.79%	-2.48%	-0.21%	-0.22%
1 Month Performance	-0.88%	-2.84%	1.13%	0.77%
1 Year Performance	-20.97%	-21.92%	15.50%	31.57%

Crescent Capital BDC Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCAP Crescent Capital BDC	4.7446 of 5 stars	$11.27 +0.7%	$13.90 +23.3%	-22.3%	$415.30M	$167.29M	27.49	N/A	Dividend Cut
CGBD Carlyle Secured Lending	2.77 of 5 stars	$11.05 +0.8%	$12.50 +13.1%	-22.8%	$767.98M	$255.57M	15.56	N/A
MFIC MidCap Financial Investment	1.4842 of 5 stars	$10.11 +0.5%	$11.54 +14.1%	-20.9%	$832.76M	$320.88M	252.81	N/A
SLRC SLR Investment	4.5038 of 5 stars	$12.49 -0.4%	$14.40 +15.3%	-24.2%	$681.45M	$218.54M	7.62	N/A	Positive News
BCSF Bain Capital Specialty Finance	2.2018 of 5 stars	$12.51 +1.1%	$14.00 +11.9%	-18.3%	$811.33M	$273.24M	10.97	1,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CCAP) was last updated on 6/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Crescent Capital BDC (CCAP) Competitors

CCAP vs. CGBD, MFIC, SLRC, BCSF, and GSBD

How does Crescent Capital BDC compare to Carlyle Secured Lending?

Summary

How does Crescent Capital BDC compare to MidCap Financial Investment?

Summary

How does Crescent Capital BDC compare to SLR Investment?

Summary

How does Crescent Capital BDC compare to Bain Capital Specialty Finance?

Summary

How does Crescent Capital BDC compare to Goldman Sachs BDC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCAP vs. The Competition

Crescent Capital BDC Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Crescent Capital BDC (CCAP) Competitors

CCAP vs. CGBD, MFIC, SLRC, BCSF, and GSBD

How does Crescent Capital BDC compare to Carlyle Secured Lending?

Which has stronger valuation & earnings, CGBD or CCAP?

Does the media favor CGBD or CCAP?

Do analysts recommend CGBD or CCAP?

Which has more risk & volatility, CGBD or CCAP?

Is CGBD or CCAP more profitable?

Do insiders and institutionals hold more shares of CGBD or CCAP?

Is CGBD or CCAP a better dividend stock?

Summary

How does Crescent Capital BDC compare to MidCap Financial Investment?

Do analysts rate CCAP or MFIC?

Does the media prefer CCAP or MFIC?

Which has more volatility and risk, CCAP or MFIC?

Which has better valuation & earnings, CCAP or MFIC?

Is CCAP or MFIC a better dividend stock?

Is CCAP or MFIC more profitable?

Do insiders & institutionals believe in CCAP or MFIC?

Summary

How does Crescent Capital BDC compare to SLR Investment?

Which has more risk and volatility, CCAP or SLRC?

Do analysts prefer CCAP or SLRC?

Is CCAP or SLRC more profitable?

Which has preferable earnings & valuation, CCAP or SLRC?

Is CCAP or SLRC a better dividend stock?

Does the media refer more to CCAP or SLRC?

Do insiders and institutionals believe in CCAP or SLRC?

Summary

How does Crescent Capital BDC compare to Bain Capital Specialty Finance?

Which has more volatility & risk, CCAP or BCSF?

Does the media favor CCAP or BCSF?

Do analysts rate CCAP or BCSF?

Do institutionals & insiders have more ownership in CCAP or BCSF?

Is CCAP or BCSF a better dividend stock?

Is CCAP or BCSF more profitable?

Which has stronger earnings & valuation, CCAP or BCSF?

Summary

How does Crescent Capital BDC compare to Goldman Sachs BDC?

Which has more risk and volatility, CCAP or GSBD?

Is CCAP or GSBD a better dividend stock?

Do insiders & institutionals believe in CCAP or GSBD?

Is CCAP or GSBD more profitable?

Which has preferable valuation and earnings, CCAP or GSBD?

Do analysts recommend CCAP or GSBD?

Does the media refer more to CCAP or GSBD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCAP vs. The Competition

Crescent Capital BDC Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools